419 related articles for article (PubMed ID: 12619575)
1. [Lactulose in treatment of hepatic encephalopathy in patient with liver cirrhosis].
Shuliat'ev IS; Il'chenko LIu; Vinnitskaia EV; Petrakov AV; Sil'verstrova SIu
Eksp Klin Gastroenterol; 2002; (5):38-41, 127. PubMed ID: 12619575
[TBL] [Abstract][Full Text] [Related]
2. [Lactulose in the therapy of porto-systemic encephalopathy].
Almici C; Inzoli MR; Poloni AE; Zambruni A
Minerva Med; 1973 Dec; 64(87):4596-603. PubMed ID: 4774227
[No Abstract] [Full Text] [Related]
3. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
[TBL] [Abstract][Full Text] [Related]
4. Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy.
Sharma P; Sharma BC; Sarin SK
Eur J Gastroenterol Hepatol; 2010 May; 22(5):526-31. PubMed ID: 20009938
[TBL] [Abstract][Full Text] [Related]
5. [Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment].
Butti A; Bianco S; Bergonzi P; Cagossi M; Civello IM; Borzone A; Nanni G; Pigliucci GM
Chir Patol Sper; 1975 Apr; 23(2):77-95. PubMed ID: 1140038
[No Abstract] [Full Text] [Related]
6. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
Sharma P; Sharma BC; Sarin SK
Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy.
Watanabe A; Sakai T; Sato S; Imai F; Ohto M; Arakawa Y; Toda G; Kobayashi K; Muto Y; Tsujii T; Kawasaki H; Okita K; Tanikawa K; Fujiyama S; Shimada S
Hepatology; 1997 Dec; 26(6):1410-4. PubMed ID: 9397979
[TBL] [Abstract][Full Text] [Related]
8. Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactulose.
Riggio O; Balducci G; Ariosto F; Merli M; Tremiterra S; Ziparo V; Capocaccia L
Hepatogastroenterology; 1990 Oct; 37(5):524-7. PubMed ID: 2253931
[TBL] [Abstract][Full Text] [Related]
9. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy.
Prasad S; Dhiman RK; Duseja A; Chawla YK; Sharma A; Agarwal R
Hepatology; 2007 Mar; 45(3):549-59. PubMed ID: 17326150
[TBL] [Abstract][Full Text] [Related]
10. [Cirrhotic liver gives up in breaking up of ammonia. Poison for the brain].
MMW Fortschr Med; 2004 Jan; 146(5):51. PubMed ID: 15035428
[No Abstract] [Full Text] [Related]
11. [Effects of lactulose treatment on the course of subclinical hepatic encephalopathy].
Zeng Z; Li YY
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1126-9. PubMed ID: 12921628
[TBL] [Abstract][Full Text] [Related]
12. [Lactulose in the treatment of chronic portosystemic encephalopathies].
Seidlová V
Cesk Gastroenterol Vyz; 1974 Apr; 28(3):201-7. PubMed ID: 4447986
[No Abstract] [Full Text] [Related]
13. Prevalence of latent portasystemic encephalopathy in an unselected population of patients with liver cirrhosis in general practice.
Schomerus H; Schreiegg J
Z Gastroenterol; 1993 Apr; 31(4):231-4. PubMed ID: 8493802
[TBL] [Abstract][Full Text] [Related]
14. Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients.
Bajaj JS; Sanyal AJ; Bell D; Gilles H; Heuman DM
Aliment Pharmacol Ther; 2010 May; 31(9):1012-7. PubMed ID: 20136802
[TBL] [Abstract][Full Text] [Related]
15. Hepatic Encephalopathy.
Blei AT; Córdoba J;
Am J Gastroenterol; 2001 Jul; 96(7):1968-76. PubMed ID: 11467622
[TBL] [Abstract][Full Text] [Related]
16. Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
Singh J; Sharma BC; Puri V; Sachdeva S; Srivastava S
Metab Brain Dis; 2017 Apr; 32(2):595-605. PubMed ID: 28070704
[TBL] [Abstract][Full Text] [Related]
17. Cirrhosis, hyperammonemia and Lactulose.
Rottiers R; Van Egmond J; Verbruggen R; Dierick G; Vermeulen A; Standaert L; De Groote J; Demeulenaere L
Tijdschr Gastroenterol; 1968; 11(2):123-39. PubMed ID: 5679042
[No Abstract] [Full Text] [Related]
18. [A clinical comparative study of crystalline pure lactulose and powder pure lactitol in portasystemic encephalopathy of cirrhotic patients].
Grandi M; Sacchetti C; Pederzoli S; Celani MF
Minerva Gastroenterol Dietol; 1991; 37(4):225-30. PubMed ID: 1805974
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of acute and chronic hepatic encephalopathy in cirrhosis].
Doffoel M; Bockel R
Ann Gastroenterol Hepatol (Paris); 1984; 20(3):163-6. PubMed ID: 6529174
[No Abstract] [Full Text] [Related]
20. Selective amono acid solutions in hepatic encephalopathy treatment (a preliminary report).
Fiaccadori F; Ghinelli F; Pelosi G; Sacchini D; Vaona GL; Zeneroli ML; Rocchi E; Santunione V; Gibertini P; Ventura E
Ric Clin Lab; 1980; 10(2):411-22. PubMed ID: 7455531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
